This inventor holds 0 USPTO granted patents, plus 2 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Dirk Grimm - Innovator in Gene Therapy
Introduction
Dirk Grimm is a notable inventor based in Germany, recognized for his contributions to the field of gene therapy. His innovative work focuses on the development of recombinant adeno-associated virus (rAAV) virions, which have significant implications for treating various diseases.
Latest Patents
Dirk Grimm holds a patent for "A Modified Raav Capsid Protein For Gene Therapy." This invention relates to rAAV virions that comprise a novel capsid protein. The application of these virions is particularly aimed at gene therapy for treating arthritic diseases, such as rheumatoid arthritis, preferably through intraarticular administration. Despite having 0 patents, his research is pivotal in advancing therapeutic techniques.
Career Highlights
Grimm is currently associated with MeiraGTx UK Ltd, where he continues to push the boundaries of gene therapy research. His work is characterized by a commitment to improving treatment options for patients suffering from debilitating conditions.
Collaborations
Dirk collaborates with various professionals in the field, including his coworker Kathleen Borner, to enhance the effectiveness of gene therapy solutions.
Conclusion
Dirk Grimm's innovative approach to gene therapy exemplifies the potential of scientific research to transform medical treatments. His contributions are vital in the ongoing quest to develop effective therapies for challenging diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile